Some Glypican-3 antibodies in CTs [211]; JX-594 (oncolytic virus) targeting HCC cells in CT [212,213], anti-CTLA-4/PD-1 (immune checkpoint inhibitors ) in CTs [210]. Here, CTLA4 is linked to hepatocellular carcinoma.